Hong Kong Auto Stock News

SEHK:2361
SEHK:2361Healthcare Services

Discover 3 Asian Penny Stocks With At Least US$300M Market Cap

Amid a backdrop of global economic shifts, Asian markets have been navigating a complex landscape influenced by geopolitical tensions and evolving trade dynamics. In this context, penny stocks—often associated with smaller or emerging companies—continue to capture investor interest due to their potential for growth despite being considered niche investments today. As we explore three noteworthy Asian penny stocks, we focus on those that combine solid financial health with the promise of...
SEHK:1478
SEHK:1478Electronic

Q Technology (Group) (SEHK:1478) Stock Valuation After Latest Camera And LiDAR Sales Update

Sales update and why it matters for Q Technology (Group) Q Technology (Group) (SEHK:1478) has released unaudited May 2026 sales volumes, providing fresh data on demand for its camera modules, LiDAR products, and biological recognition modules across mobile and other fields. For May, the company reported total sales volume of 47,484,000 camera modules and LiDAR units, alongside 13,805,000 biological recognition modules. Year to date, mobile phone camera modules reached 199,538,000 units, with...
SEHK:440
SEHK:440Banks

Dah Sing Financial Holdings (SEHK:440) Stock After Governance Changes And P/E Premium Evaluation

Dah Sing Financial Holdings (SEHK:440) has announced several governance changes, including appointing KPMG as auditor after PwC’s retirement and adding experienced Norinchukin executive Kiyoshige Uesugi to the board, drawing attention to oversight and risk control. See our latest analysis for Dah Sing Financial Holdings. The HK$40.7 share price has had a mixed few months, with a 1-day share price return of 5.82% and a 30-day share price return that declined 4.10%. However, a 1-year total...
SEHK:1138
SEHK:1138Oil and Gas

3 Asian Stocks Estimated To Be Trading At Up To 21.8% Below Intrinsic Value

Amidst global economic fluctuations and geopolitical tensions, Asian markets have been navigating a complex landscape marked by mixed signals from trade data and inflationary pressures. As investors seek opportunities within this environment, identifying undervalued stocks becomes crucial, especially those trading below their intrinsic value, offering potential for growth despite prevailing uncertainties.
SEHK:2490
SEHK:2490Shipping

Asian Penny Stocks To Watch In June 2026

As global markets navigate a complex landscape of geopolitical tensions and economic shifts, Asia's financial scene remains a focal point for investors seeking growth opportunities. Despite the challenges, penny stocks in this region continue to attract attention due to their affordability and potential for significant returns. Often representing smaller or emerging companies, these stocks can offer compelling investment opportunities when they demonstrate strong financial health and growth...
SEHK:506
SEHK:506Beverage

China Foods (SEHK:506) Stock After Dividend Approval Weighing A Low P/E Against DCF Concerns

Dividend approval and audit reappointment set the stage for China Foods China Foods (SEHK:506) drew investor attention after its 9 June 2026 AGM, where shareholders approved a final ordinary dividend of RMB 0.154 per share and reappointed Baker Tilly Hong Kong Limited as auditor. See our latest analysis for China Foods. At a share price of HK$3.46, China Foods has seen its 1 year total shareholder return of 17.51% contrast with a weaker year to date share price return of a 19.53% decline,...
SEHK:293
SEHK:293Airlines

Does Cathay Pacific (SEHK:293) CFO Succession Hint At A Shift In Financial Strategy Priorities?

Cathay Pacific Airways has announced that Chief Financial Officer and Executive Director Rebecca Jane Sharpe will retire from the Swire group on 1 October 2026, to be succeeded by Gavin John March, currently finance director at Swire Bulk Holdings. The planned handover to March, who brings aviation, engineering and shipping finance experience from across the Swire group, reshapes the airline’s senior financial leadership profile. We’ll now examine how this planned CFO transition to Gavin...
SEHK:3933
SEHK:3933Pharmaceuticals

United Laboratories International (SEHK:3933) Stock Valuation After New TUL321 Clinical Trial Approval

Clinical trial approval for TUL321 puts United Laboratories in focus United Laboratories International Holdings (SEHK:3933) has received approval from China's National Medical Products Administration to begin clinical trials for TUL321, an autoimmune drug that already holds U.S. FDA Investigational New Drug clearance. See our latest analysis for United Laboratories International Holdings. Those clinical trial and buyback announcements come after a tough spell for the stock. The 1-year total...
SEHK:772
SEHK:772Media

China Literature (SEHK:772) Stock After Board And Governance Shake Up How Does The Valuation Stack Up

Board changes put governance and oversight in focus China Literature (SEHK:772) used its 2 June annual general meeting to reshuffle its independent board lineup, introduce fresh expertise in law and accounting, and approve updated constitutional documents. For investors, these moves raise practical questions about how audit quality, risk oversight, and intellectual property decisions might be handled over the coming years, especially given the company’s role within Tencent’s broader content...
SEHK:960
SEHK:960Real Estate

Is Longfor (SEHK:960) Quietly Rewriting Its Balance Sheet Story With Steady Sales And De-Stocking?

In May 2026, Longfor Group Holdings reported unaudited contracted sales of RMB3.32 billion for the month and RMB13.67 billion for the first five months, alongside RMB11.14 billion of aggregated revenue from property operation and services and the acquisition of a new 76,985 sqm land plot for RMB374 million. Morgan Stanley highlighted Longfor Group’s proactive de-stocking approach and improving mall rental performance as key elements in its ongoing balance sheet risk reduction efforts. We’ll...
SEHK:6855
SEHK:6855Biotechs

Ascentage Pharma (SEHK:6855) Stock After New ASCO 2026 Data A Fresh Look At Valuation

Ascentage Pharma Group International (SEHK:6855) drew fresh market attention after presenting new ASCO 2026 data on olverembatinib in chronic myeloid leukemia and first clinical results for alrizomadlin in pediatric sarcomas. See our latest analysis for Ascentage Pharma Group International. The ASCO 2026 updates arrived as the stock posted a 3.93% 1 day share price gain to HK$34.9. That move sits against a year to date share price decline of 31.43% and a 1 year total shareholder return that...
SEHK:2228
SEHK:2228Life Sciences

XtalPi Biopharma GPCR Pact Tests AI Drug Discovery And Revenue Potential

XtalPi Holdings (SEHK:2228) has entered a new partnership with a major international biopharma company to develop oral small molecule drugs targeting a complex GPCR. The collaboration uses XtalPi's AI and quantum physics platforms, combined with automated labs, to work on challenging GPCR targets. The deal carries a potential value of more than US$400 million, reflecting meaningful commercial scope for XtalPi's technology. XtalPi Holdings trades at HK$7.04, with the share price down 6.0%...
SEHK:918
SEHK:918Retail Distributors

Majestic Dragon AeroTech (SEHK:918) Stock Faces Bullish Narratives As First Half EPS Turns Positive

Majestic Dragon AeroTech Holdings (SEHK:918) has released fresh numbers for FY 2026, with first half revenue of HK$75.8 million and basic EPS of HK$0.005443 setting the tone for how you might read the rest of the year. The company reported revenue of HK$18.1 million in the first half of FY 2025 and HK$100.6 million in the second half of FY 2025, with EPS shifting from a loss of HK$0.014725 to a loss of HK$0.00439. The latest positive EPS print therefore sits against a mixed recent history...
SEHK:1913
SEHK:1913Luxury

Prada (SEHK:1913) Stock After NASA Spacewear Move Is It Still Undervalued

Prada (SEHK:1913) has attracted fresh attention after unveiling an inner-layer garment for NASA astronauts, created with Axiom Space. This signals a push beyond traditional luxury products into space-related apparel. See our latest analysis for Prada. The HK$40.58 share price has been supported by short term momentum, with a 1 day share price return of 3.79% and a 7 day share price return of 10.45%. However, the 1 year total shareholder return is down 9.83%, pointing to a stock still...
SEHK:2382
SEHK:2382Electronic

Sunny Optical Technology (Group) (SEHK:2382) Stock After Index Removal How Does The Valuation Stack Up Now

Sunny Optical Technology (Group) (SEHK:2382) has been removed from the Hang Seng China Enterprises Index. This change can affect index-tracking flows and how some institutional investors view the stock. See our latest analysis for Sunny Optical Technology (Group). The index removal comes after a sharp 12.8% decline in the 7 day share price return, even though the 30 day and 90 day share price returns of 8.74% and 26.86% point to recovering momentum from a HK$71.55 base. This compares with a 1...
SEHK:285
SEHK:285Electronic

Is BYD Electronic (SEHK:285) Quietly Reframing Its Governance Story With New Independent Directors?

BYD Electronic (International) Company Limited announced at its 9 June 2026 AGM that it approved a 2025 final dividend of RMB 0.156 per share and confirmed board changes, including the retirement of two independent non-executive directors. The appointment of industry veteran Ms. Rong Xiu-li and accounting expert Professor Mr. Cao Yu-shan to lead key board committees materially reshapes the company’s governance profile. We will now examine how these refreshed independent appointments,...
SEHK:2269
SEHK:2269Life Sciences

WuXi Biologics (SEHK:2269) Stock After Regulatory Jitters And A 76.5% Five Year Slide

If you are trying to figure out whether WuXi Biologics (Cayman) is attractively priced or not, a useful starting point is to separate short term share price noise from the company’s underlying value. The stock last closed at HK$31.08. The share price is up 11.0% over the past year but down 5.1% over the past week, 8.2% over the past month and 34.5% over three years, while the five year return is down 76.5%. Recent headlines around WuXi Biologics (Cayman) have focused on broader sector...
SEHK:220
SEHK:220Food

Uni-President China Holdings (SEHK:220) Stock After Dividend Approval How Does The Valuation Stack Up

Dividend approval puts Uni-President China Holdings (SEHK:220) in focus Uni-President China Holdings (SEHK:220) has drawn investor attention after its annual general meeting approved a final dividend of 47.47 RMB cents per share for the 2025 financial year. The payout goes to shareholders on the register as of 15 June 2026. Dividend cheques are expected to be mailed on or around 8 July 2026, providing investors with clearer information on upcoming cash returns. See our latest analysis for...
SEHK:9992
SEHK:9992Specialty Retail

Pop Mart (SEHK:9992) Stock Valuation After Global Expansion Push Beyond Labubu Collaborations

Pop Mart International Group (SEHK:9992) is back in focus after management stressed that overseas growth is not solely tied to Labubu, even as the company presses ahead with more than 100 planned U.S. stores and a Labubu film collaboration. See our latest analysis for Pop Mart International Group. The recent focus on U.S. expansion and the Labubu film tie up comes after a period where the share price has been under pressure, with the 1 year total shareholder return down 31.68% even as the 3...